Fig. 6
From: Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
The docking results of proteins encoded by prognostic genes with small molecular compounds. The docking results of BMP4 with Octreotide (a). The docking results of CXCL11 with Calcitriol (b). The docking results of ILIRL1with Cyclosporine (c).The docking results of CELSR3 with Emodin (d). The docking results of EGR2 with Cyclosporine (e). The docking results of GLDC with Abrine (g) and Coumarin (h).The docking results of PCDHGA3 with Raloxifene Hydrochloride (f). The docking results of SCGB2A2 with Triptonide (i). The docking results of TRO with Rotenone (j). The docking results of UGT2B11 with Obeticholic acid (k).
